SO
KERX

STRS Ohio’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

STRS Ohio’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-75,500
Closed -$961K – 1998
2015
Q1 		$961K Buy
75,500
+900
+1% +$11.6K ﹤0.01% 807
2014
Q4 		$1.06M Hold
74,600
– – ﹤0.01% 773
2014
Q3 		$1.03M Buy
74,600
+3,200
+4% +$49K ﹤0.01% 743
2014
Q2 		$1.1M Buy
71,400
+3,700
+5% +$52.4K ﹤0.01% 733
2014
Q1 		$1.15M Sell
67,700
-12,700
-16% -$192K 0.01% 674
2013
Q4 		$1.04M Sell
80,400
-25,700
-24% -$307K ﹤0.01% 724
2013
Q3 		$1.07M Sell
106,100
-13,300
-11% -$118K ﹤0.01% 776
2013
Q2 		$892K Buy
+119,400
New +$933K ﹤0.01% 924

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

STRS Ohio's KERX Position: Q2 2015 in Review

STRS Ohio sold out of Keryx Biopharmaceuticals Inc (KERX) in Q2 2015, closing a stake of 75,500 shares — an estimated $961K sold.

STRS Ohio first reported a position in KERX in Q2 2013 and held it in 8 quarters. The position peaked at $1.15M in Q1 2014. 153 funds tracked by Wall St. Rank hold KERX as of Q2 2015.

  • STRS Ohio reported no remaining Keryx Biopharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • STRS Ohio sold 75,500 Keryx Biopharmaceuticals Inc shares in Q2 2015, an estimated $961K.
  • STRS Ohio first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 8 quarters.
  • STRS Ohio's Keryx Biopharmaceuticals Inc position peaked at $1.15M in Q1 2014.
  • 153 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q2 2015.

Based on STRS Ohio's 13F filing for Q2 2015, filed 4 Aug 2015.